160 related articles for article (PubMed ID: 1386578)
1. In vitro interaction of fenretinide with plasma retinol-binding protein and its functional consequences.
Berni R; Formelli F
FEBS Lett; 1992 Aug; 308(1):43-5. PubMed ID: 1386578
[TBL] [Abstract][Full Text] [Related]
2. Secretion of vitamin A and retinol-binding protein into plasma is depressed in rats by N-(4-hydroxyphenyl)retinamide (fenretinide).
Smith JE; Lawless DC; Green MH; Moon RC
J Nutr; 1992 Oct; 122(10):1999-2009. PubMed ID: 1388202
[TBL] [Abstract][Full Text] [Related]
3. Retinoid binding to retinol-binding protein and the interference with the interaction with transthyretin.
Malpeli G; Folli C; Berni R
Biochim Biophys Acta; 1996 May; 1294(1):48-54. PubMed ID: 8639713
[TBL] [Abstract][Full Text] [Related]
4. Secretion of N-(4-hydroxyphenyl) retinamide-retinol-binding protein from liver parenchymal cells: evidence for reduced affinity of the complex for transthyretin.
Holven KB; Natarajan V; Gundersen TE; Moskaug JO; Norum KR; Blomhoff R
Int J Cancer; 1997 May; 71(4):654-9. PubMed ID: 9178822
[TBL] [Abstract][Full Text] [Related]
5. Alteration of retinol-binding-protein concentrations by the synthetic retinoid fenretinide in healthy human subjects.
Dimitrov NV; Meyer CJ; Perloff M; Ruppenthal MM; Phillipich MJ; Gilliland D; Malone W; Minn FL
Am J Clin Nutr; 1990 Jun; 51(6):1082-7. PubMed ID: 2140925
[TBL] [Abstract][Full Text] [Related]
6. The interaction of N-ethyl retinamide with plasma retinol-binding protein (RBP) and the crystal structure of the retinoid-RBP complex at 1.9-A resolution.
Zanotti G; Malpeli G; Berni R
J Biol Chem; 1993 Nov; 268(33):24873-9. PubMed ID: 8227049
[TBL] [Abstract][Full Text] [Related]
7. N-(4-hydroxyphenyl)retinamide (fenretinide) induces retinol-binding protein secretion from liver and accumulation in the kidneys in rats.
Schaffer EM; Ritter SJ; Smith JE
J Nutr; 1993 Sep; 123(9):1497-503. PubMed ID: 8360775
[TBL] [Abstract][Full Text] [Related]
8. N-(4-hydroxyphenyl)retinamide: interactions with retinoid-binding proteins/receptors.
Sani BP; Shealy YF; Hill DL
Carcinogenesis; 1995 Oct; 16(10):2531-4. PubMed ID: 7586162
[TBL] [Abstract][Full Text] [Related]
9. Retinol-binding protein secretion from the liver of N-(4-hydroxyphenyl) retinamide-treated rats.
Ritter SJ; Smith JE
Biochim Biophys Acta; 1996 Jun; 1290(2):157-64. PubMed ID: 8645719
[TBL] [Abstract][Full Text] [Related]
10. Plasma retinol level reduction by the synthetic retinoid fenretinide: a one year follow-up study of breast cancer patients.
Formelli F; Carsana R; Costa A; Buranelli F; Campa T; Dossena G; Magni A; Pizzichetta M
Cancer Res; 1989 Nov; 49(21):6149-52. PubMed ID: 2529028
[TBL] [Abstract][Full Text] [Related]
11. Retinoids: in vitro interaction with retinol-binding protein and influence on plasma retinol.
Berni R; Clerici M; Malpeli G; Cleris L; Formelli F
FASEB J; 1993 Sep; 7(12):1179-84. PubMed ID: 8375617
[TBL] [Abstract][Full Text] [Related]
12. Interactions with retinol and retinoids of bovine cellular retinol-binding protein.
Malpeli G; Stoppini M; Zapponi MC; Folli C; Berni R
Eur J Biochem; 1995 Apr; 229(2):486-93. PubMed ID: 7744071
[TBL] [Abstract][Full Text] [Related]
13. Crystallographic studies on complexes between retinoids and plasma retinol-binding protein.
Zanotti G; Marcello M; Malpeli G; Folli C; Sartori G; Berni R
J Biol Chem; 1994 Nov; 269(47):29613-20. PubMed ID: 7961949
[TBL] [Abstract][Full Text] [Related]
14. Identification of the fenretinide metabolite 4-oxo-fenretinide present in human plasma and formed in human ovarian carcinoma cells through induction of cytochrome P450 26A1.
Villani MG; Appierto V; Cavadini E; Valsecchi M; Sonnino S; Curley RW; Formelli F
Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6265-75. PubMed ID: 15448016
[TBL] [Abstract][Full Text] [Related]
15. Biotransformation and protein binding of N-(4-hydroxyphenyl)retinamide in murine mammary epithelial cells.
Bunk MJ; Kinahan JJ; Sarkar NH
Cancer Lett; 1985 Apr; 26(3):319-26. PubMed ID: 2986832
[TBL] [Abstract][Full Text] [Related]
16. Plasma retinol-binding protein: structure and interactions with retinol, retinoids, and transthyretin.
Zanotti G; Berni R
Vitam Horm; 2004; 69():271-95. PubMed ID: 15196886
[TBL] [Abstract][Full Text] [Related]
17. The piscine plasma retinol-binding protein. Purification, partial amino acid sequence and interaction with mammalian transthyretin of rainbow trout (Oncorhynchus mykiss) retinol-binding protein.
Berni R; Stoppini M; Zapponi MC
Eur J Biochem; 1992 Feb; 204(1):99-106. PubMed ID: 1740159
[TBL] [Abstract][Full Text] [Related]
18. The Ile-84-->Ser amino acid substitution in transthyretin interferes with the interaction with plasma retinol-binding protein.
Berni R; Malpeli G; Folli C; Murrell JR; Liepnieks JJ; Benson MD
J Biol Chem; 1994 Sep; 269(38):23395-8. PubMed ID: 8089102
[TBL] [Abstract][Full Text] [Related]
19. Study on the mechanism of interference of 3,4,3',4'-tetrachlorobiphenyl with the plasma retinol-binding proteins in rodents.
Brouwer A; Blaner WS; Kukler A; Van den Berg KJ
Chem Biol Interact; 1988; 68(3-4):203-17. PubMed ID: 3145817
[TBL] [Abstract][Full Text] [Related]
20. Lack of correlation between plasmatic levels of retinol and RBP and thyroid hormones in breast cancer patients treated with the synthetic retinoid fenretinide.
Pizzichetta M; Formelli F; Bombardieri E; Bruni GF; Costa A
Int J Biol Markers; 1990; 5(4):208. PubMed ID: 2151235
[No Abstract] [Full Text] [Related]
[Next] [New Search]
